Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer
NCT ID: NCT01937533
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2013-10-02
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study hypothesis is that this technique will be able to differentiate tumours with histological features known to be associated with poor prognosis (tumour type, grade and lymphovascular space invasion).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repetitive Functional Imaging in Locally Advanced Cervical Cancer
NCT01989364
Lab-on-a-chip Detection of Cervical Cancer Tumour Markers
NCT03380741
An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)
NCT05532930
New Indications for Ultrasound in the Staging of Cervical Cancer
NCT00451945
Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT00193934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical Cancer
Patients with presumed early cervical cancer being considered for curative surgery
Magnetic Resonance Imaging using an endovaginal receiver coil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Resonance Imaging using an endovaginal receiver coil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* claustrophobia (MRI incompatibility)
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Research UK
OTHER
Institute of Cancer Research, United Kingdom
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nandita deSouza
Professor of Translational Imaging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nandita deSouza, Professor
Role: PRINCIPAL_INVESTIGATOR
ICR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13/EE/0198 CCR3938
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.